G2B Pharma's Unattributed Round

G2B Pharma raised a round of funding on June 11, 2013.

G2B Pharma is a privately-held developmental stage specialty pharmaceutical company, focused on the reformulation of off-patent drugs. The company's mission is to take drugs that have recently come of…

Articles about G2B Pharma's Unattributed Round: